Activity of AZD7442 (tixagevimab-cilgavimab) against Omicron SARS-CoV-2 in patients with hematologic malignancies.

ABSTRACT:

SUBMITTER: Stuver R 

PROVIDER: S-EPMC9108069 | biostudies-literature | 2022 Jun

REPOSITORIES: biostudies-literature